The World Health Organization (WHO) Blood Regulators Network (BRN) was established in 2006 and is comprised of leading international regulatory authorities that have responsibility for the regulation of blood, blood products and related in vitro diagnostic devices (IVD).
The Expert Committee on Biological Standardization (ECBS) recognized the need for a global network of regulatory authorities in the blood field and recommended that WHO promote cooperation of experienced regulatory authorities in risk assessment and information-sharing through the establishment of a "peer regulators group".
Member organizations have legal standing and well-established, demonstrated institutional capacity to regulate blood and blood products, and the necessary expertise to address emerging global public health challenges. The WHO acts as Secretariat to the BRN and coordinates network activities under the conditions of the Terms of Reference.
Related documents
Position Statement on Storage Age of Red Blood Cells (RBC)
Position Paper on Use of Convalescent Plasma, Serum or Immune Globulin Concentrates as an Element in Response to an Emerging Virus
Potential for Use of Convalescent Plasma in Management of Ebola
Position Statement on Collection of Blood for Transfusion in the Setting of a Vaccination Campaign Against Yellow Fever
Position Paper on Collection and Use of Convalescent Plasma or Serum as an Element in Filovirus Outbreak Response
Position Paper on Collection and Use of Convalescent Plasma or Serum as an Element in Middle East Respiratory Syndrome Coronavirus Response
WHO Standard Organ Transplant Nomenclature (Version 1.0)
First Advisory Meeting for the SONG project (Standardization of Organ Nomenclature Globally) in collaboration with the ICCBBA, Geneva, 4-5 May 2011 Report
Position Statement on Use of Pathogen‐Reduced Cryoprecipitate in Settings Where Commercial Clotting Factor Concentrates are Unavailable or Unaffordable
Position Paper on Collection and Use of Convalescent Plasma or Serum as an Element in Pandemic Influenza Planning
Position Statement on Reports of Inferior Clinical Outcomes with Transfusion of Older vs. Younger Stored Red Blood Cells
Donor selection in case of pandemic situations
Xenotransplantation Advisory Consultation, Geneva, 18-20 April 2005
Statement From the Xenotransplantation Advisory Consultation, Geneva, 18-20 April 2005
Blood Regulators Network (BRN) members
The BRN is comprised of the following Regulatory Authorities.